Evidence map›Paper›PMID 41922371›Full record

ArticleNature communications2026

Quantifying yield losses from Bt resilience among maize cultivars in South Africa.

Jesse Tack, Courtney F Cooper, Lawton Lanier Nalley, Petronella Chaminuka, Safiah Maali, Erin E Farmer, Michael A Gore

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jesse TackDepartment of Agricultural Economics, Kansas State University, Manhattan, KS, USA. jtack@ksu.edu.ORCID 0000-0003-1186-7462
Courtney F CooperDepartment of Agricultural Economics and Agribusiness, University of Arkansas, Fayetteville, AR, USA.
Lawton Lanier NalleyDepartment of Agricultural Economics and Agribusiness, University of Arkansas, Fayetteville, AR, USA.
Petronella ChaminukaAgricultural Research Council, Pretoria, South Africa.
Safiah MaaliAgricultural Research Council - Grain Crops, Potchefstroom, South Africa.
Erin E FarmerPlant Breeding and Genetics Section, School of Integrative Plant Science, Cornell University, Ithaca, NY, USA.
Michael A GorePlant Breeding and Genetics Section, School of Integrative Plant Science, Cornell University, Ithaca, NY, USA.ORCID 0000-0001-6896-8024

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetically modified crops have provided economic and social benefits since becoming commercially available. One of the most successful and widely used applications is the integration of genes from the soil bacterium Bacillus thuringiensis for protection against damaging pests. Here, we leverage a robust dataset of 85,133 field-trial maize observations spanning all major production regions in South Africa from 1980-2018 to estimate yield gains associated with the first wave of genetically modified cultivars and explore the potential dynamic erosion of these gains since resistance was reported among first wave of single gene Bacillus thuringiensis cultivars. Leveraging the cultivars commercial release year, we find that genetically modified yield gains increased dynamically from their initial introduction in 2000, peaking at approximately 0.55 MT/ha around 2006, after which they significantly eroded to near-zero by 2014. Interestingly, this erosion was followed by a dramatic rebound in gains, reaching an in-sample high of approximately 0.75 MT/ha.

Indexed as

Bacillus thuringiensisCrops, AgriculturalPlants, Genetically ModifiedZea maysBacterial ProteinsPest Control, BiologicalSouth AfricaBacterial Proteins

Identifiers

PMID41922371
PMCPMC13212967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.